Evidence Library
Tier 1 — UK official
23 sources. Lower tiers are used only where higher tiers are silent, and the reason is recorded on the source.
- Cirrhosis in over 16s: assessment and management (NG50)
National Institute for Health and Care Excellence · 2016-07-06 · Tier 1
Current — checked with the publisher on 2026-09-01 · 23 claims - Liver disease quality standard (QS152)
National Institute for Health and Care Excellence · 2017-06-29 · Tier 1
Current — checked with the publisher on 2026-09-01 · 1 claim - POL195 - Liver Transplantation: Selection Criteria and Recipient Registration
NHS Blood and Transplant · 2026-07-31 · Tier 1
Current — checked with the publisher on 2026-09-01 · 3 claims - POL196 - Deceased Donor Liver Distribution and Allocation
NHS Blood and Transplant · 2026-08-03 · Tier 1
Current — checked with the publisher on 2026-09-01 · 5 claims - Advanced therapy medicinal products: regulation and licensing in UK
Medicines and Healthcare products Regulatory Agency / GOV.UK · 2015-01-26 · Tier 1
Current — checked with the publisher on 2026-09-01 · unread - Cirrhosis
NHS · 2025-02-10 · Tier 1
Current — checked with the publisher on 2026-09-01 · 10 claims - Alcohol-related liver disease (ARLD)
NHS · 2026-07-15 · Tier 1
Current — checked with the publisher on 2026-09-01 · 11 claims - Treating paracetamol overdose with intravenous acetylcysteine: new guidance
Medicines and Healthcare products Regulatory Agency / GOV.UK Drug Safety Update · 2014-12-11 · Tier 1
Current — checked with the publisher on 2026-09-01 · 5 claims - TOXBASE clinical toxicology database
National Poisons Information Service · date not established · Tier 1
Status not established — not checked with the publisher · unread - Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49)
National Institute for Health and Care Excellence · 2016-07-06 · Tier 1
Under review — checked with the publisher on 2026-09-01 · 1 claim - Acute upper gastrointestinal bleeding in over 16s: management (CG141)
National Institute for Health and Care Excellence · 2012-06-13 · Tier 1
Current — checked with the publisher on 2026-09-01 · 5 claims - Acute upper gastrointestinal bleeding in adults (QS38)
National Institute for Health and Care Excellence · 2013-07-30 · Tier 1
Current — checked with the publisher on 2026-09-01 · 1 claim - Alcohol-use disorders: diagnosis and management of physical complications (CG100)
National Institute for Health and Care Excellence · 2010-06-02 · Tier 1
Current — checked with the publisher on 2026-09-01 · 5 claims - Terlipressin: new recommendations to reduce risks of respiratory failure and septic shock in patients with type 1 hepatorenal syndrome
Medicines and Healthcare products Regulatory Agency · 2023-03 · Tier 1
Current — checked with the publisher on 2026-09-01 · 6 claims - Liver cancer
NHS · 2023-06-13 · Tier 1
Current — checked with the publisher on 2026-09-01 · 8 claims - Liver cancer
NHS inform (NHS Scotland) · 2026-02-16 · Tier 1
Current — checked with the publisher on 2026-09-01 · 2 claims - Extracorporeal albumin dialysis for acute liver failure (HTG202, formerly IPG316)
National Institute for Health and Care Excellence · 2009-09-23 · Tier 1
Current — checked with the publisher on 2026-09-02 · 4 claims - Extracorporeal whole liver perfusion for acute liver failure (HTG573, formerly IPG690)
National Institute for Health and Care Excellence · 2021-03-31 · Tier 1
Current — checked with the publisher on 2026-09-02 · 1 claim - Service Specification 170003/S: Liver Transplantation Service (Adults)
NHS England · 2017-04-10 · Tier 1
Current — checked with the publisher on 2026-09-02 · 1 claim - Etranacogene dezaparvovec for treating moderately severe or severe haemophilia B (TA989)
National Institute for Health and Care Excellence · 2024-07-24 · Tier 1
Current — checked with the publisher on 2026-09-02 · 2 claims - Hemgenix 1 x 10^13 genome copies/mL concentrate for solution for infusion - Summary of Product Characteristics
CSL Behring GmbH, via the electronic Medicines Compendium · 2026-04-21 · Tier 1
Current — checked with the publisher on 2026-09-02 · 4 claims - The Human Medicines Regulations 2012, regulation 2A: definition of advanced therapy medicinal product
UK Statutory Instruments, via legislation.gov.uk · 2012 · Tier 1
Current — checked with the publisher on 2026-09-02 · 1 claim - Lumasiran for treating primary hyperoxaluria type 1 (HST25)
National Institute for Health and Care Excellence · 2022-11-16 · Tier 1
Current — checked with the publisher on 2026-09-02 · 1 claim